Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy (Q37670302)

21 August 2017

0 references

Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy (English)

1 reference

21 August 2017

1 reference

Vassili Valayannopoulos

2

object named as

Vassili Valayannopoulos

1 reference

21 August 2017

0 references

8

Patrick Niaudet

1 reference

21 August 2017

Hanna Debiec

1

1 reference

21 August 2017

Olivia Boyer

3

1 reference

21 August 2017

Laure-Hélène Nöel

4

1 reference

21 August 2017

Patrice Callard

5

1 reference

21 August 2017

Hélène Sarda

6

1 reference

21 August 2017

Pascale de Lonlay

7

1 reference

21 August 2017

Pierre Ronco

9

1 reference

21 August 2017

language of work or name

1 reference

21 November 2013

1 reference

Journal of the American Society of Nephrology

21 August 2017

1 reference

21 August 2017

25

1 reference

21 August 2017

675-680

1 reference

21 August 2017

4

1 reference

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Early-childhood membranous nephropathy due to cationic bovine serum albumin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Mucopolysaccharidosis VI.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Podocyte glutamatergic signaling contributes to the function of the glomerular filtration barrier.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

The molecular basis of lysosomal storage diseases and their treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Immune response to enzyme replacement therapy in lysosomal storage disorder patients and animal models.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Pathogenesis of membranous nephropathy: recent advances and future challenges

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Human podocytes possess a stretch-sensitive, Ca2+-activated K+ channel: potential implications for the control of glomerular filtration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Inhibition of the human intermediate conductance Ca(2+)-activated K(+) channel, hIK1, by volatile anesthetics.

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3968491

Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies

1 September 2018

1 reference

12 December 2020

The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family

1 reference

12 December 2020

Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies

1 reference

12 December 2020

Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease

1 reference

12 December 2020

Immunosurveillance of alglucerase enzyme therapy for Gaucher patients: induction of humoral tolerance in seroconverted patients after repeat administration

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

1 reference

12 December 2020

Human idiopathic membranous nephropathy--a mystery solved?

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2013030290

1 reference

21 August 2017

1 reference

21 August 2017

1 reference